Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c489b9daec2da53d6956d1450d5a7a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0255c6d0a3f4fc3f4eef171cab0a1e6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba626e65611392f08f423ac7d6710500 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf0f68bc9b66c444a1b7b970ce248f7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06Q30-0217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06Q30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
filingDate |
2004-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff01578ee0109419f38f7451da20bc57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c7ed611f783e755b6ab9bb77c9306f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4aa0e46112236252054b8c2969abf28 |
publicationDate |
2004-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004069199-A2 |
titleOfInvention |
Marketing system for improving patient compliance and methods and devices relating to same |
abstract |
The present invention provides a marketing system and methods for marketing a dosage form comprising interferon gamma (IFN-γ) to a patient in need thereof, for the treatment of idiopathic pulmonary fibrosis (IPF). The present invention further provides a method for increasing patient compliance. The present invention further provides methods of treatment and dosage forms compatible for use in the marketing systems and methods of the invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005097188-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005097188-A2 |
priorityDate |
2003-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |